New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Allarity Therapeutics, Inc.
ALLR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Biotechnology

Next Earning date - 12 Nov 2024

2M

Biotechnology

Next Earning date - 12 Nov 2024

1.39USD
Shape-0.08 ( -5.44%)
favorite-chart

Relative Strenght

0
favorite-chart

Volume Buzz

-70%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated October 13, 2024
1W -15.24 % 1M -58.88 % 3M -76.72 % 1Y -99.68 %

Key Metrics

Shape
  • Market Cap

    1.96M


  • Shares Outstanding

    1.41M


  • Share in Float

    939472


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.39


  • Average Volume

    450082


  • Beta

    0.285


  • Range

    1.37-666.0


  • Industry

    Biotechnology


  • Website

    https://www.allarity.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

17.53x

P/S Ratio

1.05x

P/B Ratio

0.1

Debt/Equity

-11380.4%

Net Margin

$-11.0

EPS

How ALLR compares to sector?

P/E Ratio

Relative Strength

Shape

ALLR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$49M

ShapeNaN%

2025-Revenue

$46.80

Shape-42445%

2025-EPS

$29M

Shape965%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-951.05
vs 8.28

Q4.22

arrow
arrow

N/A

-0.23
vs -102.08

Q1.23

arrow
arrow

N/A

-177.20
vs -13.93

Q2.23

arrow
arrow

N/A

-26.28
vs -0.52

Q3.23

arrow
arrow

N/A

-2.24
vs -951.05

Q4.23

arrow
arrow

N/A

-0.43
vs -0.23

Q1.24

arrow
arrow

N/A

-22.14
vs -177.20

Q2.24

arrow
arrow

N/A

-3.30
vs -26.28

Q3.24

arrow
arrow

N/A

-8.40
vs -2.24

Q4.24

arrow
arrow

N/A

-8.10
vs -0.43

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

112K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-144%

-1.44
vs -0.57

Q4.22

arrow
arrow

-150%

-1.50
vs -1.44

Q1.23

arrow
arrow

+927%

9.27
vs -1.50

Q2.23

arrow
arrow

+329%

3.29
vs 9.27

Q3.23

arrow
arrow

+164%

1.64
vs 3.29

Q4.23

arrow
arrow

+63%

0.63
vs 1.64

Q1.24

arrow
arrow

+59%

0.59
vs 0.63

Q2.24

arrow
arrow

-8%

-0.08
vs 0.59

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

2

2
vs NA

NA

Q1.22

arrow
arrow

9

9
vs 2

350%

Q2.22

arrow
arrow

8

8
vs 9

-11%

Q3.22

arrow
arrow

8

8
vs 8

NA

Q4.22

arrow
arrow

10

10
vs 8

25%

Earnings Growth

Latest News